Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Novonesis A S ADR (NVZMY)

Novonesis A S ADR (NVZMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 26,510,408
  • Shares Outstanding, K 468,299
  • Annual Sales, $ 2,599 M
  • Annual Income, $ 439,080 K
  • EBIT $ 577 M
  • EBITDA $ 577 M
  • 60-Month Beta 0.87
  • Price/Sales 10.10
  • Price/Cash Flow 59.46
  • Price/Book 12.59
  • Price/Earnings ttm 35.44
  • Earnings Per Share ttm 1.58
  • Most Recent Earnings $0.36 on 02/01/24
  • Next Earnings Date 12/26/24 [--]
  • Annual Dividend & Yield 0.35 (0.62%)
  • Most Recent Dividend 0.165 on 09/09/24
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.49
  • Growth Rate Est. (year over year) +203,777.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.0000 +1.09%
on 12/19/24
60.1600 -5.90%
on 11/25/24
-0.6500 (-1.14%)
since 11/20/24
3-Month
55.0001 +2.93%
on 11/18/24
72.5000 -21.92%
on 09/30/24
-12.0500 (-17.55%)
since 09/20/24
52-Week
49.9900 +13.24%
on 01/18/24
72.5000 -21.92%
on 09/30/24
+3.4300 (+6.45%)
since 12/20/23

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the...

See More

Key Turning Points

3rd Resistance Point 57.4900
2nd Resistance Point 57.1600
1st Resistance Point 56.8850
Last Price 56.6100
1st Support Level 56.2800
2nd Support Level 55.9500
3rd Support Level 55.6750

See More

52-Week High 72.5000
Fibonacci 61.8% 63.9012
Fibonacci 50% 61.2450
Fibonacci 38.2% 58.5888
Last Price 56.6100
52-Week Low 49.9900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar